 Evoke Pharma EVOK stock is rocketing higher on Wednesday after the company got Medicaid approval for its GIMOTI nasal spray. The post Evoke Pharma EVOK Stock Soars 50 on Medicaid Drug Approval appeared first on InvestorPlace. 